Skip to main content
OpenTrials

Clinical trial condition

Stage IVA Oropharyngeal Squamous Cell Carcinoma

Explore clinical trials studying Stage IVA Oropharyngeal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IVA Oropharyngeal Squamous Cell Carcinoma trial results

Completed

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

NCT02254278

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 222 locations
View Trial Details
Completed

Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

NCT03342911

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +27 more
Locations
  • Abington- Jefferson Health Abington, Pennsylvania, United States
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

NCT03422536

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +41 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

NCT01256385

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 24 locations
View Trial Details
Completed

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

NCT02007200

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +42 more
Locations
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions